CryoPort (NASDAQ:CYRX) Lowered to Sell Rating by Wall Street Zen

CryoPort (NASDAQ:CYRX) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday.

Several other brokerages have also weighed in on CYRX. Needham & Company LLC raised their target price on CryoPort from $12.00 to $13.00 and gave the stock a “buy” rating in a research report on Wednesday. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of CryoPort in a report on Monday, December 29th. Eight research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $12.94.

CryoPort Stock Down 3.2%

Shares of NASDAQ:CYRX opened at $8.09 on Friday. CryoPort has a fifty-two week low of $4.63 and a fifty-two week high of $11.45. The firm’s 50 day moving average price is $9.43 and its 200 day moving average price is $9.39. The company has a quick ratio of 15.01, a current ratio of 15.77 and a debt-to-equity ratio of 0.40. The stock has a market cap of $405.07 million, a price-to-earnings ratio of 6.13 and a beta of 1.69.

CryoPort (NASDAQ:CYRX) last posted its quarterly earnings results on Tuesday, March 3rd. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.19) by ($0.02). CryoPort had a negative return on equity of 8.33% and a net margin of 42.35%.The firm had revenue of $45.45 million for the quarter, compared to analyst estimates of $42.92 million. As a group, equities research analysts predict that CryoPort will post -0.99 earnings per share for the current fiscal year.

Insider Buying and Selling at CryoPort

In related news, Director Ramkumar Mandalam sold 11,570 shares of the company’s stock in a transaction on Wednesday, December 10th. The shares were sold at an average price of $9.99, for a total value of $115,584.30. Following the completion of the sale, the director owned 80,758 shares in the company, valued at $806,772.42. This represents a 12.53% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 10.00% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the stock. LPL Financial LLC raised its stake in shares of CryoPort by 6.6% during the 4th quarter. LPL Financial LLC now owns 23,306 shares of the company’s stock worth $224,000 after buying an additional 1,433 shares in the last quarter. The Manufacturers Life Insurance Company lifted its holdings in shares of CryoPort by 9.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 18,178 shares of the company’s stock valued at $136,000 after buying an additional 1,557 shares during the period. State of Wyoming boosted its stake in shares of CryoPort by 30.2% in the second quarter. State of Wyoming now owns 14,218 shares of the company’s stock valued at $106,000 after buying an additional 3,301 shares in the last quarter. Intech Investment Management LLC boosted its stake in shares of CryoPort by 14.6% in the second quarter. Intech Investment Management LLC now owns 25,951 shares of the company’s stock valued at $194,000 after buying an additional 3,305 shares in the last quarter. Finally, Basepoint Wealth LLC acquired a new position in CryoPort during the fourth quarter worth $34,000. 92.90% of the stock is currently owned by hedge funds and other institutional investors.

CryoPort Company Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.